Jon Birchall, Julia Black and Sharon Kell recently visited Bristol-Myers Squibb (BMS), one of the leading pharmaceutical companies pioneering new immunotherapy treatments to fight cancer. During his visit, Jon took part in BMS’s Global Patient Week where he was able to share his kidney cancer journey, from diagnosis to treatment, to help employees better understand a patients’ perspectives on the disease and its treatment. Jon and his wife, Sarah, had previously made a video about his kidney cancer experience. This video and Jon’s presentation were shared simultaneously with around 20,000 BMS employees located in BMS offices around the world. Jon is pictured with (l-r) Davide Piras (BMS Head of EMAC region), Mary Beth Harler (BMS, Head of Innovative Medicines Development), Amber Shotton (psoriasis patient), Veronique Walsh (BMS General Manger UK/IE), Jon, Giovanni Caforio (CEO of BMS Worldwide Global), Sharon and Julia (KCSN).
KCSN partners with the pharmaceutical industry, research institutes, hospitals and clinics to improve understanding of the kidney cancer patient journey and to highlight the various issues faced by patients during their care and treatment. Our goal is that this collaborative approach between patients and professionals will eventually lead to a more patient-centred approach to the care and treatment pathway for kidney cancer, so that patients become more involved in shared decisions about their treatment options. Please contact Rose or Julia for support, information or a friendly person to chat to on our confidential helpline 01209 890326, or join our closed FaceBook group to meet and chat with other kidney cancer patients and carers.